VEGFA and lung carcinoma: Unilateral, unifocal metastases are more common in lung cancer cases [1] and the median survival time for patients with choroidal metastases originating from primary lung cancer is less than 8 months [2] Traditionally, choroidal metastases are treated with local therapy, including external beam radiotherapy, brachytherapy, transpupillary thermotherapy [3], or more recently, photodynamic therapy (PDT) [4] and anti-vascular endothelial growth factor therapy (anti-VEGF) [5, 6].